🔎 Trials Near Me

መነሻ › ማኩላር ዴጀነሬሽን › ካሊፎርኒያ

በካሊፎርኒያ ለማኩላር ዴጀነሬሽን የሚደረጉ ክሊኒካዊ ጥናቶች

ለማኩላር ዴጀነሬሽን የሚደረጉ 20 ጥናቶች በካሊፎርኒያ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።

በካሊፎርኒያ ውስጥ ያሉ ከተሞች

Official study text (English)

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

  • Global Research Management, Inc., Glendale
  • Retinal Consultants Medical Group (Site 024), Modesto
  • Azul Vision / California Eye Specialists Medical Group, Inc., Pasadena
  • እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Retina Consultants of Orange County, Fullerton
  • Shiley Eye Institute Jacobs Retina Center, La Jolla
  • California Retina Consultants, Oxnard
  • እና 3 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06635148

A Study in Adults With Geographic Atrophy

  • California Retina Consultants, Bakersfield
  • Retina-Vitreous Associates Medical Group, Beverly Hills
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07606365

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • Retina Vitreous Associates Medical Group, Beverly Hills
  • Retina Specialists of Beverly Hills- Department of Ophthalmology, Beverly Hills
  • Eye Medical Center of Fresno, Fresno
  • እና 19 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ50 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ18 ሴፕቴ 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • California Retina Consultants, Bakersfield
  • Retina-Vitreous Associates Medical Group, Beverly Hills
  • Macula and Retina Institute, Glendale
  • እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06659445

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • Jules Stein Eye Institute, Los Angeles
  • Stanford University Byers Eye Institute, Palo Alto
  • Kaiser Permanente Riverside Medical Center, Riverside
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT03178149

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

  • Retina Consultants San Diego, Poway
ተሳታዮችን በመፈለግ ላይ
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ኦገስ 2026 · NCT06662162

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

  • Stanford University School of Medicine, Palo Alto
  • University of California Health - UC Davis, Sacramento
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 6 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT07425574

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

  • California Retina Consultants, Oxnard
  • Retinal Consultants Medical Group, Sacramento
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ኦገስ 2026 · NCT05197270

A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

  • Retina-Vitreous Associates Medical Group, Beverly Hills
  • Bay Area Retina Associates, Walnut Creek
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT06659549

Phase 1 Study of C.001 in Retinal Degeneration

  • Retina Vision Consultants, Beverly Hills
  • Palo Alto Medical Foundation, Palo Alto
  • Retinal Consultants Medical Group, Sacramento
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT07594236

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  • The Retina Partners, Encino
  • Northern California Retina Vitreous Associates Medical Group, Inc., Mountain View
  • Orange County Retina Medical Group, Santa Ana
ተሳታዮችን በመፈለግ ላይደረጃ 2/3
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT07496567

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

  • Adverum site 109, Bakersfield
  • Adverum site 169, Fullerton
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦገስ 2026 · NCT07630649

Effects of Goji vs. Fiber on Macular Degeneration

  • UC Davis Eye Center, Tschannen Eye Institute, Sacramento
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ65 እስከ 95 · ሁሉም ጾታዎች · የተሻሻለው በ17 ጁላይ 2026 · NCT06237127

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

  • Beverly Hills, CA, Beverly Hills
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ጁላይ 2026 · NCT07587515

Village-Integrated Eye Worker Trial II

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁን 2026 · NCT03752840

Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 55 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ኤፕሪ 2026 · NCT07556406

Strategies for Improving Linkage-to-Care After Eye Disease Screening

  • University of California, San Francisco, San Francisco
ተሳታዮችን በመፈለግ ላይ
እድሜ 60 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ኤፕሪ 2026 · NCT06943599

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

  • Retinal Diagnostic Center, Campbell
  • Retina Consultants of Orange County, Fullerton
  • Northern California Retina Vitreous Associates, Mountain View
  • እና 4 ተጨማሪ
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 50 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT07064759

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Loma Linda University, Loma Linda
  • Eye Physicians of Long Beach, Long Beach
ተሳታዮችን በመፈለግ ላይ
እድሜ 65 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ዲሴም 2024 · NCT05438732

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።